Biotech News

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

Si-Bone (SIBN)Si-Bone2026-06-25 13:46 ESTEarnings

SANTA CLARA, Calif. , Oct. 20, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the third quarter of 2025 after market close on Monday, November 10, 2025 .

Open original release

Related news

Si-Bone

Si-Bone is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States